dc.contributor.author | Sevinir, B. | |
dc.contributor.author | Olgun, N. | |
dc.contributor.author | Tugcu, D. | |
dc.contributor.author | Kebudi, Rejin | |
dc.contributor.author | Unal, E. | |
dc.contributor.author | Ince, D. | |
dc.contributor.author | Kurucu, N. | |
dc.contributor.author | Varan, A. | |
dc.contributor.author | Akici, F. | |
dc.contributor.author | Demirag, B. | |
dc.contributor.author | Cecen, E. | |
dc.contributor.author | Ozyoruk, D. | |
dc.contributor.author | Ozguven, A. | |
dc.contributor.author | Kose, D. | |
dc.contributor.author | Hazar, V. | |
dc.contributor.author | Bozkurt, C. | |
dc.contributor.author | Apak, H. | |
dc.contributor.author | Kupeli, S. | |
dc.contributor.author | Sari, N. | |
dc.contributor.author | Cakir, F. | |
dc.contributor.author | Citak, C. | |
dc.contributor.author | Yoruk, A. | |
dc.contributor.author | Tokuc, G. | |
dc.contributor.author | Oguz, A. | |
dc.contributor.author | Beker, B. | |
dc.contributor.author | Yildirim, Z. | |
dc.contributor.author | Unal, E. | |
dc.contributor.author | Kantar, M. | |
dc.contributor.author | Yesil, S. | |
dc.contributor.author | Emir, S. | |
dc.contributor.author | Corapcioglu, F. | |
dc.contributor.author | Oniz, H. | |
dc.contributor.author | Dagdemir, A. | |
dc.contributor.author | Erbay, A. | |
dc.contributor.author | Kizmazoglu, D. | |
dc.contributor.author | Koksal, Y. | |
dc.contributor.author | Aksoylar, S. | |
dc.contributor.author | Guler, E. | |
dc.date.accessioned | 2021-03-02T16:02:28Z | |
dc.date.available | 2021-03-02T16:02:28Z | |
dc.identifier.citation | Ince D., Kurucu N., Varan A., Akici F., Demirag B., Cecen E., Sevinir B., Kebudi R., Tugcu D., Guler E., et al., "Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Intermediate Risk Group Treatment Results", PEDIATRIC BLOOD & CANCER, cilt.67, 2020 | |
dc.identifier.issn | 1545-5009 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_f707913b-2225-4804-a8b5-e86e6bc57b0c | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/2153 | |
dc.language.iso | eng | |
dc.subject | Hematoloji | |
dc.subject | Tıp | |
dc.subject | PEDİATRİ | |
dc.subject | HEMATOLOJİ | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.subject | Health Sciences | |
dc.subject | Hematology | |
dc.subject | Pediatrics, Perinatology and Child Health | |
dc.subject | Oncology | |
dc.subject | Pediatrics | |
dc.subject | Onkoloji | |
dc.subject | İç Hastalıkları | |
dc.subject | Çocuk Sağlığı ve Hastalıkları | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.title | Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Intermediate Risk Group Treatment Results | |
dc.type | Makale | |
dc.relation.journal | PEDIATRIC BLOOD & CANCER | |
dc.contributor.department | Dokuz Eylül Üniversitesi , , | |
dc.identifier.volume | 67 | |
dc.contributor.firstauthorID | 2488242 | |